Cargando…
The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany
In May 2021, the Alpha variant (B.1.1.7) of SARS-CoV-2 was found in 91% of the SARS-CoV-2 cases in Germany. Not much is known about the symptoms, courses of disease, and infectiousness in pediatric patients with the Alpha variant. Objective: The aim of this retrospective analysis was to gain informa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402740/ https://www.ncbi.nlm.nih.gov/pubmed/34452464 http://dx.doi.org/10.3390/v13081600 |
_version_ | 1783745863179304960 |
---|---|
author | Meyer, Meike Holfter, Anna Ruebsteck, Esra Gruell, Henning Dewald, Felix Koerner, Robert Walter Klein, Florian Lehmann, Clara Huenseler, Christoph Weber, Lutz Thorsten |
author_facet | Meyer, Meike Holfter, Anna Ruebsteck, Esra Gruell, Henning Dewald, Felix Koerner, Robert Walter Klein, Florian Lehmann, Clara Huenseler, Christoph Weber, Lutz Thorsten |
author_sort | Meyer, Meike |
collection | PubMed |
description | In May 2021, the Alpha variant (B.1.1.7) of SARS-CoV-2 was found in 91% of the SARS-CoV-2 cases in Germany. Not much is known about the symptoms, courses of disease, and infectiousness in pediatric patients with the Alpha variant. Objective: The aim of this retrospective analysis was to gain information on the infection with the Alpha variant in children and adolescents. Methods: Between 12 January 2021 and 3 June 2021, all nucleic acid amplification tests (NAATs) of children who received a swab for SARS-CoV-2 were included. Data were collected on standardized questionnaires. The analysis of data was anonymized and retrospective. Results: We investigated 3544 NAATs; 95 children were tested positive (2.7%) for SARS-CoV-2. For the sub-analysis, 65 children were analyzed. In 59 children, the Alpha variant was found (90.8%), and 54.2% (n = 32/59) were symptomatic. The most common symptoms were fever, cough, and rhinitis. The median Ct value was 24.0 (min 17.0; max 32.7). Conclusions: We can underline early findings that children are still less effected by SARS-CoV-2 infection with the spread of the Alpha variant. We found no evidence that children infected with the Alpha variant showed more severe symptoms or suffered from a more severe clinical course than those infected with the wild type. |
format | Online Article Text |
id | pubmed-8402740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84027402021-08-29 The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany Meyer, Meike Holfter, Anna Ruebsteck, Esra Gruell, Henning Dewald, Felix Koerner, Robert Walter Klein, Florian Lehmann, Clara Huenseler, Christoph Weber, Lutz Thorsten Viruses Article In May 2021, the Alpha variant (B.1.1.7) of SARS-CoV-2 was found in 91% of the SARS-CoV-2 cases in Germany. Not much is known about the symptoms, courses of disease, and infectiousness in pediatric patients with the Alpha variant. Objective: The aim of this retrospective analysis was to gain information on the infection with the Alpha variant in children and adolescents. Methods: Between 12 January 2021 and 3 June 2021, all nucleic acid amplification tests (NAATs) of children who received a swab for SARS-CoV-2 were included. Data were collected on standardized questionnaires. The analysis of data was anonymized and retrospective. Results: We investigated 3544 NAATs; 95 children were tested positive (2.7%) for SARS-CoV-2. For the sub-analysis, 65 children were analyzed. In 59 children, the Alpha variant was found (90.8%), and 54.2% (n = 32/59) were symptomatic. The most common symptoms were fever, cough, and rhinitis. The median Ct value was 24.0 (min 17.0; max 32.7). Conclusions: We can underline early findings that children are still less effected by SARS-CoV-2 infection with the spread of the Alpha variant. We found no evidence that children infected with the Alpha variant showed more severe symptoms or suffered from a more severe clinical course than those infected with the wild type. MDPI 2021-08-12 /pmc/articles/PMC8402740/ /pubmed/34452464 http://dx.doi.org/10.3390/v13081600 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meyer, Meike Holfter, Anna Ruebsteck, Esra Gruell, Henning Dewald, Felix Koerner, Robert Walter Klein, Florian Lehmann, Clara Huenseler, Christoph Weber, Lutz Thorsten The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany |
title | The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany |
title_full | The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany |
title_fullStr | The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany |
title_full_unstemmed | The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany |
title_short | The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany |
title_sort | alpha variant (b.1.1.7) of sars-cov-2 in children: first experience from 3544 nucleic acid amplification tests in a cohort of children in germany |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402740/ https://www.ncbi.nlm.nih.gov/pubmed/34452464 http://dx.doi.org/10.3390/v13081600 |
work_keys_str_mv | AT meyermeike thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT holfteranna thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT ruebsteckesra thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT gruellhenning thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT dewaldfelix thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT koernerrobertwalter thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT kleinflorian thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT lehmannclara thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT huenselerchristoph thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT weberlutzthorsten thealphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT meyermeike alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT holfteranna alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT ruebsteckesra alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT gruellhenning alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT dewaldfelix alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT koernerrobertwalter alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT kleinflorian alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT lehmannclara alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT huenselerchristoph alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany AT weberlutzthorsten alphavariantb117ofsarscov2inchildrenfirstexperiencefrom3544nucleicacidamplificationtestsinacohortofchildreningermany |